Table 10.
Stability in diluent data of identified markers in 10 mg/mL and 100 mg/mL formulations.
| Formulation strength: 10 mg/mL | ||||||
|---|---|---|---|---|---|---|
| Retention Time (min) |
||||||
| Time Interval | Storage Conditions | Gallic Acid | Catechin | Rosmarinic Acid | Andrographolide | Curcumin |
| Initial | CRT | 5.293 | 12.174 | 19.823 | 21.448 | 26.307 |
| 2–8 °C | 5.264 | 12.024 | 19.805 | 21.415 | 26.273 | |
| 4 h | CRT | 5.263 | 12.154 | 19.820 | 21.430 | 26.301 |
| 2–8 °C | 5.230 | 12.013 | 19.804 | 21.415 | 26.270 | |
| 24 h | CRT | 5.217 | 12.012 | 19.801 | 21.412 | 26.265 |
| 2–8 °C | 5.397 | 12.579 | 19.884 | 21.493 | 26.399 | |
| Formulation strength: 100 mg/mL | ||||||
| Retention Time (min) |
||||||
| Time Interval | Storage Conditions | Gallic Acid | Catechin | Rosmarinic Acid | Andrographolide | Curcumin |
| Initial | CRT | 5.232 | 11.906 | 19.738 | 21.346 | 26.164 |
| 2–8 °C | 5.100 | 12.179 | 19.782 | 21.384 | 26.251 | |
| 4 h | CRT | 5.142 | 11.908 | 19.727 | 21.335 | 26.144 |
| 2–8 °C | 5.090 | 12.216 | 19.798 | 21.402 | 26.281 | |
| 24 h | CRT | 5.045 | 12.220 | 19.779 | 21.393 | 26.258 |
| 2–8 °C | 5.064 | 12.056 | 19.771 | 21.390 | 26.351 | |